Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06172010 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection

Study acronym: RiCOTTA
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this Dutch multicenter clinical trial, patients with a staphylococcal prosthetic joint infection, will, in the oral antibiotic treatment phase, be randomized between clindamycin monotherapy and rifampicin / levofloxacin combination therapy. The clinical endpoint will be treatment success one year after finishing antimicrobial treatment.
Trial Details
NCT Number NCT06172010
Lead Sponsor Leiden University Medical Center
Collaborators: University Medical Center Groningen, Onze Lieve Vrouwe Gasthuis, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Frisius Medisch Centrum, Isala, Martini Hospital Groningen, Radboud University Medical Center, Sint Maartenskliniek, Elisabeth-TweeSteden Ziekenhuis, Erasmus Medical Center, Alrijne Hospital, Spaarne Gasthuis, Reinier Haga Orthopedisch Centrum, Tergooi Hospital, Rijnstate Hospital
Conditions Prosthetic-joint Infection, Infection Hip, Infection; Knee, Joint
Enrollment 316 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov